Arnulf I, Rico TJ, Mignot E Diagnosis, disease course, and management of patients with Kleine-Levin syndrome. Lancet Neurol. 2012 Oct;11(10):918-28. doi: 10.1016/S1474-4422(12)70187-4. Review.
Bassetti C, Aldrich MS Idiopathic hypersomnia. A series of 42 patients. Brain. 1997 Aug;120 ( Pt 8):1423-35.
Brankack J, Kukushka VI, Vyssotski AL, Draguhn A EEG gamma frequency and sleep-wake scoring in mice: comparing two types of supervised classifiers. Brain Res. 2010 Mar 31;1322:59-71. doi: 10.1016/j.brainres.2010.01.069. Epub 2010 Feb 1.
CRITCHLEY M Periodic hypersomnia and megaphagia in adolescent males. Brain. 1962 Dec;85:627-56.
Fraiwan L, Lweesy K, Khasawneh N, Wenz H, Dickhaus H Automated sleep stage identification system based on time-frequency analysis of a single EEG channel and random forest classifier. Comput Methods Programs Biomed. 2012 Oct;108(1):10-9. doi: 10.1016/j.c
Frenette E, Kushida CA Primary hypersomnias of central origin. Semin Neurol. 2009 Sep;29(4):354-67. doi: 10.1055/s-0029-1237114. Epub 2009 Sep 9. Review.
Guilleminault C, Lopes MC, Hagen CC, da Rosa A The cyclic alternating pattern demonstrates increased sleep instability and correlates with fatigue and sleepiness in adults with upper airway resistance syndrome. Sleep. 2007 May;30(5):641-7.
Hadjiyannakis K, Ogilvie RD, Alloway CE, Shapiro C FFT analysis of EEG during stage 2-to-REM transitions in narcoleptic patients and normal sleepers. Electroencephalogr Clin Neurophysiol. 1997 Nov;103(5):543-53.
Jaussent I, Morin CM, Ivers H, Dauvilliers Y Incidence, worsening and risk factors of daytime sleepiness in a population-based 5-year longitudinal study. Sci Rep. 2017 May 2;7(1):1372. doi: 10.1038/s41598-017-01547-0.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
